Christian Rolfo
@christianrolfo.bsky.social
Director Division of Medical Oncology. Assoc Director Early Phase Clinical Trials The James Comprehensive Cancer Center. Professor at The OSU.Liquid Biopsy T/RT my own #liquidbiopsy #biomarkers #lungcancer #drugdevelopment
Reposted by Christian Rolfo
🩸🚀 New Insights in Liquid Biopsy! 🧬
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
International Society of Liquid Biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
Circulating tumor DNA (ctDNA) testing has transformed precision oncology by enabling
the non-invasive detection of actionable mutations. To facilitate broader clinical
adoption and improve testing acc...
www.journalofliquidbiopsy.com
May 31, 2025 at 6:16 AM
🩸🚀 New Insights in Liquid Biopsy! 🧬
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
Reposted by Christian Rolfo
🚨Excited to represent the @islb.info at #ASCO25!
Swing by our booth, we’re ready to talk about #LiquidBiopsy and opportunities!
Got questions about the society? We’ve got answers. Come to connect!🩸
@ascocancer.bsky.social @christianrolfo.bsky.social @rolfolab.bsky.social
Swing by our booth, we’re ready to talk about #LiquidBiopsy and opportunities!
Got questions about the society? We’ve got answers. Come to connect!🩸
@ascocancer.bsky.social @christianrolfo.bsky.social @rolfolab.bsky.social
May 27, 2025 at 4:07 PM
🚨Excited to represent the @islb.info at #ASCO25!
Swing by our booth, we’re ready to talk about #LiquidBiopsy and opportunities!
Got questions about the society? We’ve got answers. Come to connect!🩸
@ascocancer.bsky.social @christianrolfo.bsky.social @rolfolab.bsky.social
Swing by our booth, we’re ready to talk about #LiquidBiopsy and opportunities!
Got questions about the society? We’ve got answers. Come to connect!🩸
@ascocancer.bsky.social @christianrolfo.bsky.social @rolfolab.bsky.social
Very honored of this important recognition in my born country. Blessed to share this special moment with my family, friends and great colleagues from Argentina 🇦🇷 looking forward to continue working with @UBAonline from OSU @OhioStateMedOnc ! Thanks to all my team @rolfolab.bsky.social
May 12, 2025 at 6:30 PM
Very honored of this important recognition in my born country. Blessed to share this special moment with my family, friends and great colleagues from Argentina 🇦🇷 looking forward to continue working with @UBAonline from OSU @OhioStateMedOnc ! Thanks to all my team @rolfolab.bsky.social
Reposted by Christian Rolfo
📍We proudly celebrate Prof. Christian Rolfo for being awarded the honorary title of Doctor Honoris Causa by the University of Buenos Aires! 🎓✨ Congratulations on this well-deserved recognition! @christianrolfo.bsky.social @yukselurun.bsky.social @mjoseserrano.bsky.social
May 8, 2025 at 9:37 AM
📍We proudly celebrate Prof. Christian Rolfo for being awarded the honorary title of Doctor Honoris Causa by the University of Buenos Aires! 🎓✨ Congratulations on this well-deserved recognition! @christianrolfo.bsky.social @yukselurun.bsky.social @mjoseserrano.bsky.social
Reposted by Christian Rolfo
Thanks Hope Foundation SWOG for the great honor to give the Robert Livingston Translational Cancer Lecture. In memory of a pioneer in thoracic research.Thanks @JhanelleGray @DrRoyHerbstYale for the opportunity.
@SupportingSWOG @OSUCCC_James @OhioStateMedOnc @OhioStateMedOnc
@SupportingSWOG @OSUCCC_James @OhioStateMedOnc @OhioStateMedOnc
May 8, 2025 at 3:49 PM
Reposted by Christian Rolfo
New research from the #VISION trial of #tepotinib in #NSCLC with #METex14 skipping highlights key differences when patients are identified by LBxvs TBx.
➡️ #Tepotinib showed robust efficacy regardless of biopsy type
@christianrolfo.bsky.social @oncoalert.bsky.social
➡️ #Tepotinib showed robust efficacy regardless of biopsy type
@christianrolfo.bsky.social @oncoalert.bsky.social
May 5, 2025 at 1:52 PM
New research from the #VISION trial of #tepotinib in #NSCLC with #METex14 skipping highlights key differences when patients are identified by LBxvs TBx.
➡️ #Tepotinib showed robust efficacy regardless of biopsy type
@christianrolfo.bsky.social @oncoalert.bsky.social
➡️ #Tepotinib showed robust efficacy regardless of biopsy type
@christianrolfo.bsky.social @oncoalert.bsky.social
Reposted by Christian Rolfo
🔬📈 Check out our new commentary on Selinexor (an XPO1 inhibitor) + ICIs in uveal melanoma patients in a phase 1B trial!
➡️12m OS 55 %
➡️0 % ORR
➡️manageable safety profile
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social #CarlosAyala
pmc.ncbi.nlm.nih.gov/articles/PMC...
➡️12m OS 55 %
➡️0 % ORR
➡️manageable safety profile
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social #CarlosAyala
pmc.ncbi.nlm.nih.gov/articles/PMC...
Selinexor in Uveal Melanoma: A Hopeful Step or Just Another Hurdle?
pmc.ncbi.nlm.nih.gov
May 5, 2025 at 7:45 PM
🔬📈 Check out our new commentary on Selinexor (an XPO1 inhibitor) + ICIs in uveal melanoma patients in a phase 1B trial!
➡️12m OS 55 %
➡️0 % ORR
➡️manageable safety profile
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social #CarlosAyala
pmc.ncbi.nlm.nih.gov/articles/PMC...
➡️12m OS 55 %
➡️0 % ORR
➡️manageable safety profile
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social #CarlosAyala
pmc.ncbi.nlm.nih.gov/articles/PMC...
Thanks Hope Foundation SWOG for the great honor to give the Robert Livingston Translational Cancer Lecture. In memory of a pioneer in thoracic research.Thanks @JhanelleGray @DrRoyHerbstYale for the opportunity.
@SupportingSWOG @OSUCCC_James @OhioStateMedOnc @OhioStateMedOnc
@SupportingSWOG @OSUCCC_James @OhioStateMedOnc @OhioStateMedOnc
May 4, 2025 at 5:15 AM
Thanks Hope Foundation SWOG for the great honor to give the Robert Livingston Translational Cancer Lecture. In memory of a pioneer in thoracic research.Thanks @JhanelleGray @DrRoyHerbstYale for the opportunity.
@SupportingSWOG @OSUCCC_James @OhioStateMedOnc @OhioStateMedOnc
@SupportingSWOG @OSUCCC_James @OhioStateMedOnc @OhioStateMedOnc
Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team!
@OhioStateMedOnc
@OSUCCC_James
@OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social
@OhioStateMedOnc
@OSUCCC_James
@OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social
April 25, 2025 at 2:45 PM
Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team!
@OhioStateMedOnc
@OSUCCC_James
@OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social
@OhioStateMedOnc
@OSUCCC_James
@OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social
Reposted by Christian Rolfo
Super excited to share the review I wrote with Carolina Reduzzi published in the Journal of Liquid Biopsy on the transformative impact of LB in oncology! 🩸🔬
LB is reshaping cancer care 💥
Check it out 👉 pubmed.ncbi.nlm.nih.gov/40255897/
@islb.info @christianrolfo.bsky.social @rolfolab.bsky.social
LB is reshaping cancer care 💥
Check it out 👉 pubmed.ncbi.nlm.nih.gov/40255897/
@islb.info @christianrolfo.bsky.social @rolfolab.bsky.social
April 21, 2025 at 7:51 PM
Super excited to share the review I wrote with Carolina Reduzzi published in the Journal of Liquid Biopsy on the transformative impact of LB in oncology! 🩸🔬
LB is reshaping cancer care 💥
Check it out 👉 pubmed.ncbi.nlm.nih.gov/40255897/
@islb.info @christianrolfo.bsky.social @rolfolab.bsky.social
LB is reshaping cancer care 💥
Check it out 👉 pubmed.ncbi.nlm.nih.gov/40255897/
@islb.info @christianrolfo.bsky.social @rolfolab.bsky.social
Reposted by Christian Rolfo
🚨We are hiring Medical Oncologists at @OhioStateMedOnc !
Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence
Send your applications
@OSUCCC_James @OhioStateMed
Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence
Send your applications
@OSUCCC_James @OhioStateMed
April 9, 2025 at 11:37 PM
🚨We are hiring Medical Oncologists at @OhioStateMedOnc !
Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence
Send your applications
@OSUCCC_James @OhioStateMed
Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence
Send your applications
@OSUCCC_James @OhioStateMed
Reposted by Christian Rolfo
Patients with #lungcancer enrolling to Lung-MAP can now be matched to a targeted treatment trial based on prior genomic testing, without submitting new tumor or blood samples, making Lung-MAP 3.0 accessible to more patients at a wider range of clinical sites. #lcsm
www.swog.org/news-events/...
www.swog.org/news-events/...
Lung-MAP 3.0 Expands Genomic Screening Options for Patients | SWOG
Lung-MAP is a precision medicine umbrella trial for patients with advanced non-small cell lung cancer (NSCLC), using genomic screening to match patients to investigational new treatments at more than 900 sites across the U.S. As it moves into its second decade, the trial is undergoing another major update (Lung-MAP 3.0) and greatly broadening the list of approved next-generation sequencing (NGS) genomic tests that can be used to assign patients to a targeted Lung-MAP sub-study.
www.swog.org
April 17, 2025 at 1:24 PM
Patients with #lungcancer enrolling to Lung-MAP can now be matched to a targeted treatment trial based on prior genomic testing, without submitting new tumor or blood samples, making Lung-MAP 3.0 accessible to more patients at a wider range of clinical sites. #lcsm
www.swog.org/news-events/...
www.swog.org/news-events/...
Reposted by Christian Rolfo
Make the most of your #AACR25 experience with in-person and virtual options, the AACR Runners for Research 5K Run/Walk, a performance by the CheckPoints, and more. Preview highlights in AACR Annual Meeting News: www.aacrmeetingnews.org/news/prepari...
April 13, 2025 at 3:43 PM
Make the most of your #AACR25 experience with in-person and virtual options, the AACR Runners for Research 5K Run/Walk, a performance by the CheckPoints, and more. Preview highlights in AACR Annual Meeting News: www.aacrmeetingnews.org/news/prepari...
Reposted by Christian Rolfo
Day 3 at #TexasLung25 diving into diagnostics, #MRD, and #LiquidBiopsy with an outstanding faculty! 🩸🔬
Learning from the best: @christianrolfo.bsky.social @davidgandera @WadeIams @osucccjames.bsky.social @rolfolab.bsky.social
Exciting discussions shaping the future of #lungcancer testing! 📚
Learning from the best: @christianrolfo.bsky.social @davidgandera @WadeIams @osucccjames.bsky.social @rolfolab.bsky.social
Exciting discussions shaping the future of #lungcancer testing! 📚
April 12, 2025 at 4:32 PM
Day 3 at #TexasLung25 diving into diagnostics, #MRD, and #LiquidBiopsy with an outstanding faculty! 🩸🔬
Learning from the best: @christianrolfo.bsky.social @davidgandera @WadeIams @osucccjames.bsky.social @rolfolab.bsky.social
Exciting discussions shaping the future of #lungcancer testing! 📚
Learning from the best: @christianrolfo.bsky.social @davidgandera @WadeIams @osucccjames.bsky.social @rolfolab.bsky.social
Exciting discussions shaping the future of #lungcancer testing! 📚
Congrats Roberto! And welcome to @rolfolab.bsky.social !!!
Honored to be here at hashtag #TexasLung25 in #Austin as one of the 10 winners of the poster competition 🏅
Grateful for the chance to meet with exceptional people 👐
@stephenvliu.bsky.social @tinacascone @christianrolfo.bsky.social
Grateful for the chance to meet with exceptional people 👐
@stephenvliu.bsky.social @tinacascone @christianrolfo.bsky.social
April 11, 2025 at 11:05 AM
Congrats Roberto! And welcome to @rolfolab.bsky.social !!!
🚨We are hiring Medical Oncologists at @OhioStateMedOnc !
Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence
Send your applications
@OSUCCC_James @OhioStateMed
Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence
Send your applications
@OSUCCC_James @OhioStateMed
April 9, 2025 at 11:37 PM
🚨We are hiring Medical Oncologists at @OhioStateMedOnc !
Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence
Send your applications
@OSUCCC_James @OhioStateMed
Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence
Send your applications
@OSUCCC_James @OhioStateMed
Reposted by Christian Rolfo
Navigating the future of #LiquidBiopsy with @christianrolfo.bsky.social at #poles25
From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer.
Tissue vs liquid? It’s not a battle—it’s a partnership.
@rolfolab.bsky.social @islb.info @oncoalert.bsky.social
From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer.
Tissue vs liquid? It’s not a battle—it’s a partnership.
@rolfolab.bsky.social @islb.info @oncoalert.bsky.social
April 5, 2025 at 4:49 PM
Navigating the future of #LiquidBiopsy with @christianrolfo.bsky.social at #poles25
From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer.
Tissue vs liquid? It’s not a battle—it’s a partnership.
@rolfolab.bsky.social @islb.info @oncoalert.bsky.social
From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer.
Tissue vs liquid? It’s not a battle—it’s a partnership.
@rolfolab.bsky.social @islb.info @oncoalert.bsky.social
Reposted by Christian Rolfo
🎉🩸 Thrilled to share that the Journal of Liquid Biopsy is now officially live in PubMed and PMC! A significant step forward for JLB
Check it out here: pmc.ncbi.nlm.nih.gov/journals/?te...
#LiquidBiopsy #PubMed @christianrolfo.bsky.social @yukselurun.bsky.social @eloisajantus.bsky.social
Check it out here: pmc.ncbi.nlm.nih.gov/journals/?te...
#LiquidBiopsy #PubMed @christianrolfo.bsky.social @yukselurun.bsky.social @eloisajantus.bsky.social
March 18, 2025 at 8:44 AM
🎉🩸 Thrilled to share that the Journal of Liquid Biopsy is now officially live in PubMed and PMC! A significant step forward for JLB
Check it out here: pmc.ncbi.nlm.nih.gov/journals/?te...
#LiquidBiopsy #PubMed @christianrolfo.bsky.social @yukselurun.bsky.social @eloisajantus.bsky.social
Check it out here: pmc.ncbi.nlm.nih.gov/journals/?te...
#LiquidBiopsy #PubMed @christianrolfo.bsky.social @yukselurun.bsky.social @eloisajantus.bsky.social
Reposted by Christian Rolfo
📢 Exciting update in the field of liquid biopsy! A new editorial highlights the essential role of the International Society of Liquid Biopsy (ISLB) in establishing quality framework for LB clinical implementation. 🧬🩸
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
March 18, 2025 at 2:46 PM
📢 Exciting update in the field of liquid biopsy! A new editorial highlights the essential role of the International Society of Liquid Biopsy (ISLB) in establishing quality framework for LB clinical implementation. 🧬🩸
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
Reposted by Christian Rolfo
🚨 Out in @natrevclinoncol.bsky.social
📌ctDNA helps uncover resistance mechanisms
📌Standardized protocols are crucial for improving applications
📌ctDNA + tissue provides a more comprehensive view
nature.com/articles/s41...
@christianrolfo.bsky.social @osucccjames.bsky.social
📌ctDNA helps uncover resistance mechanisms
📌Standardized protocols are crucial for improving applications
📌ctDNA + tissue provides a more comprehensive view
nature.com/articles/s41...
@christianrolfo.bsky.social @osucccjames.bsky.social
March 17, 2025 at 12:00 PM
🚨 Out in @natrevclinoncol.bsky.social
📌ctDNA helps uncover resistance mechanisms
📌Standardized protocols are crucial for improving applications
📌ctDNA + tissue provides a more comprehensive view
nature.com/articles/s41...
@christianrolfo.bsky.social @osucccjames.bsky.social
📌ctDNA helps uncover resistance mechanisms
📌Standardized protocols are crucial for improving applications
📌ctDNA + tissue provides a more comprehensive view
nature.com/articles/s41...
@christianrolfo.bsky.social @osucccjames.bsky.social
Reposted by Christian Rolfo
The HER2 protein is becoming a crucial target not only in breast cancer but also in other tumor subtypes. 🔬✨ Super experts discuss the role of IHC in #lungcancer and #ovariancancer!
@christianrolfo.bsky.social @rolfolab.bsky.social
@osucccjames.bsky.social
#HER2 #IHC #Targettherapy
@christianrolfo.bsky.social @rolfolab.bsky.social
@osucccjames.bsky.social
#HER2 #IHC #Targettherapy
JOIN US for a discussion on HER2🧬testing & evolving role of IHC🔬 in hashtag#LungCancer & hashtag#OvarianCancer
REGISTER HERE👇👇
buff.ly/7F6ztd4
JOIN US TUESDAY MARCH 11, 2025
REGISTER HERE👇👇
buff.ly/7F6ztd4
JOIN US TUESDAY MARCH 11, 2025
March 11, 2025 at 1:01 PM
The HER2 protein is becoming a crucial target not only in breast cancer but also in other tumor subtypes. 🔬✨ Super experts discuss the role of IHC in #lungcancer and #ovariancancer!
@christianrolfo.bsky.social @rolfolab.bsky.social
@osucccjames.bsky.social
#HER2 #IHC #Targettherapy
@christianrolfo.bsky.social @rolfolab.bsky.social
@osucccjames.bsky.social
#HER2 #IHC #Targettherapy
Reposted by Christian Rolfo
Diving into the latest on #METex14 skipping #NSCLC, from testing to treatment, with an outstanding panel of experts! 🌟🔬
--> bit.ly/3DFSzLi
Panelists:
@christianrolfo.bsky.social
#UmbertoMalapelle
#YasushiYatabe
#MervatMahrous
Organizer:
#touchOncology
@rolfolab.bsky.social @oncoalert.bsky.social
--> bit.ly/3DFSzLi
Panelists:
@christianrolfo.bsky.social
#UmbertoMalapelle
#YasushiYatabe
#MervatMahrous
Organizer:
#touchOncology
@rolfolab.bsky.social @oncoalert.bsky.social
March 13, 2025 at 3:25 PM
Diving into the latest on #METex14 skipping #NSCLC, from testing to treatment, with an outstanding panel of experts! 🌟🔬
--> bit.ly/3DFSzLi
Panelists:
@christianrolfo.bsky.social
#UmbertoMalapelle
#YasushiYatabe
#MervatMahrous
Organizer:
#touchOncology
@rolfolab.bsky.social @oncoalert.bsky.social
--> bit.ly/3DFSzLi
Panelists:
@christianrolfo.bsky.social
#UmbertoMalapelle
#YasushiYatabe
#MervatMahrous
Organizer:
#touchOncology
@rolfolab.bsky.social @oncoalert.bsky.social
Reposted by Christian Rolfo
✨ Insightful presentation by @manelesteller.bsky.social from
@carrerasijc.bsky.social at @osuwexmed.bsky.social
Starting from #epigenetics to #spatialtranscriptomics, unlocking a deeper understanding of tumor biology and cancer treatment! 🔬🧬💊
@christianrolfo.bsky.social @rolfolab.bsky.social
@carrerasijc.bsky.social at @osuwexmed.bsky.social
Starting from #epigenetics to #spatialtranscriptomics, unlocking a deeper understanding of tumor biology and cancer treatment! 🔬🧬💊
@christianrolfo.bsky.social @rolfolab.bsky.social
March 5, 2025 at 6:32 PM
✨ Insightful presentation by @manelesteller.bsky.social from
@carrerasijc.bsky.social at @osuwexmed.bsky.social
Starting from #epigenetics to #spatialtranscriptomics, unlocking a deeper understanding of tumor biology and cancer treatment! 🔬🧬💊
@christianrolfo.bsky.social @rolfolab.bsky.social
@carrerasijc.bsky.social at @osuwexmed.bsky.social
Starting from #epigenetics to #spatialtranscriptomics, unlocking a deeper understanding of tumor biology and cancer treatment! 🔬🧬💊
@christianrolfo.bsky.social @rolfolab.bsky.social
Reposted by Christian Rolfo
⏱️ To-do list for today: Tune in to the live webinar by
@iaslc.bsky.social covering key highlights from the 2024 Hot Topic in Basic & Translational Science Conference! 🔬🧬 Don't miss out on the latest breakthroughs!
@christianrolfo.bsky.social @rolfolab.bsky.social
www.iaslc.org/meetings-web...
@iaslc.bsky.social covering key highlights from the 2024 Hot Topic in Basic & Translational Science Conference! 🔬🧬 Don't miss out on the latest breakthroughs!
@christianrolfo.bsky.social @rolfolab.bsky.social
www.iaslc.org/meetings-web...
2024 Hot Topic in Basic & Translational Science Conference Highlights | IASLC
IASLC presents a one-hour, live session focused on key highlights from the 2024 Hot Topic in Basic & Translational Science Conference. This webinar will ser ...
www.iaslc.org
February 12, 2025 at 12:10 PM
⏱️ To-do list for today: Tune in to the live webinar by
@iaslc.bsky.social covering key highlights from the 2024 Hot Topic in Basic & Translational Science Conference! 🔬🧬 Don't miss out on the latest breakthroughs!
@christianrolfo.bsky.social @rolfolab.bsky.social
www.iaslc.org/meetings-web...
@iaslc.bsky.social covering key highlights from the 2024 Hot Topic in Basic & Translational Science Conference! 🔬🧬 Don't miss out on the latest breakthroughs!
@christianrolfo.bsky.social @rolfolab.bsky.social
www.iaslc.org/meetings-web...
Reposted by Christian Rolfo
Don't miss the chance to dive into this interesting discussion on lung cancer with an incredible faculty! 🔎🫁💊
#lungcancer
#myESMO
#DeepDiveLungCancer
@christianrolfo.bsky.social @rolfolab.bsky.social
ow.ly/vbSt50UPrrS
#lungcancer
#myESMO
#DeepDiveLungCancer
@christianrolfo.bsky.social @rolfolab.bsky.social
ow.ly/vbSt50UPrrS
February 3, 2025 at 12:56 PM
Don't miss the chance to dive into this interesting discussion on lung cancer with an incredible faculty! 🔎🫁💊
#lungcancer
#myESMO
#DeepDiveLungCancer
@christianrolfo.bsky.social @rolfolab.bsky.social
ow.ly/vbSt50UPrrS
#lungcancer
#myESMO
#DeepDiveLungCancer
@christianrolfo.bsky.social @rolfolab.bsky.social
ow.ly/vbSt50UPrrS